Company Code: 1762 Company Name: China Chemical & Pharmaceutical Co. Industry: Biomedical Industry Data Month/Year: 2026-02 Monthly Revenue: 102,881 Thousand NTD (NT$103 Million) Year-on-year Change: +161.3%
FACT BOX
- Source: PR Times
- Category: 其他
其他
[China Chemical & Pharmaceutical Co.] 2026-02 Monthly Revenue NT$103 Million (YoY +161.3%)
Citation-Grade
Primary-source linked
Schema.org verified
NQ 70 / 100
Published Feb 1, 2026 9:00 AM ・ Updated Jun 1, 2026 12:15 PM ・ 2 min read ・ Source: PR Times
Show contents
⚡ Key Points
- China Chemical & Pharmaceutical Co.
- (1762) announced that its February 2026 revenue reached NT$103 million, a significant increase of 161.3% compared to the same period last year.
- The explosive growth in revenue for this biomedical raw material pharmaceutical company may be attributed to concentrated shipments of specific drug orders.
China Chemical & Pharmaceutical Co. (1762) announced that its February 2026 revenue reached NT$103 million, a significant increase of 161.3% compared to the same period last year. The explosive growth in revenue for this biomedical raw material pharmaceutical company may be attributed to concentrated shipments of specific drug orders.
Editorial & Verification Standards
The Washin AI News desk structures and reviews this article under the following standards.
- Start only from primary sources (official PR, disclosures, wire services)
- Numbers and proper nouns machine-checked against the source (number-completeness check)
- Company names and tickers verified via registry (Registry/TWSE/Wikidata)
- No speculation; nothing stated that is not in the source
Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›
- Announced Feb 1, 2026 9:00 AM — Distributor PR Times
- Collected Apr 7, 2026 8:00 AM
- AI structured & analyzed Apr 8, 2026 12:18 AM
- Desk-reviewed & published Feb 1, 2026 9:00 AM
FAQ
What are the key facts in this article?
China Chemical & Pharmaceutical Co. (1762) announced that its February 2026 revenue reached NT$103 million, a significant increase of 161.3% compared to the same period last year. The explosive growth in revenue for this biomedical raw material pharmaceutical company may be attributed to concentrated shipments of specific drug orders.
Where is the primary source?
PR Times: https://openapi.twse.com.tw/revenue/twse-rev-1762-11502
When was it published?
Feb 1, 2026
Cite this article — HOW TO CITE
Washin AI News Desk“[China Chemical & Pharmaceutical Co.] 2026-02 Monthly Revenue NT$103 Million (YoY +161.3%)”AI News by Washin Village（和心村）, Feb 1, 2026. https://aeo.washinmura.jp/ai/%E4%B8%AD%E5%8C%96%E7%94%9F/en/news/2026-02-01-china-chemical-and-pharmaceutical-co-202
AI CRAWLER ACTIVITY
as of Jul 17, 2026
AI crawler visits to this article (cumulative)182 bots
Site-wide cumulative
Applebot
bot_visits_summary
4165k
last Jul 17, 2026
ClaudeBot
bot_visits_summary
2905k
last Jul 17, 2026
GPTBot
bot_visits_summary
2505k
last Jul 17, 2026
Bingbot
bot_visits_summary
2394k
last Jul 17, 2026
Meta AI
bot_visits_summary
1013k
last Jul 17, 2026
Google AI
bot_visits_summary
581k
last Jul 17, 2026
※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.
Washin AI News（AI News by Washin Village（和心村））
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.
Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification
Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →